Dialysis patients are at risk for low bone mineral density (BMD) conse
quent of hyperparathyroidism, 1,25-dihydroxyvitamin D deficiency, prev
ious immunosuppression, chronic acidosis, secondary amenorrhea, and ch
ronic heparin and aluminum exposure. We wanted to determine the preval
ence and distribution of osteopenia and the influence of risk factors
for osteopenia in dialysis patients. Dual energy x-ray absorptiometry
was used to record BMD at the lumbar spine (LS), hip, and nondominant
forearm. Results were expressed as Z-scores (standard deviations from
the mean of a healthy age- and gender-matched reference population). O
steopenia was defined as a Z-score worse than -2. In the 250 dialysis
patients studied, the prevalence of osteopenia at the LS, femoral neck
(FN) and ultradistal radius (UD) was 8%, 13% and 20%, respectively. T
he median Z-scores at these sites were all significantly different fro
m the healthy reference population median of 0 and were 0.29 (P = 0.00
8), -0.67 (P < 0.001), and -1.01 (P < 0.001), respectively. Previous t
ransplantation was associated with as much as a one Z-score lower BMD
at the FN (P = 0.0069) and UD (P = 0.0011) and a marginally significan
t reduction at the LS (P = 0.0777). Previous parathyroidectomy was ass
ociated with a markedly higher LS BMD (P = 0.0001) and a higher BMD at
the FN (P = 0.0017) but not the UD (P = 0.3691). A history of seconda
ry amenorrhea was associated with a lower FN BMD (P = 0.0047) but not
a significantly lower BMD at the LS (P = 0.0978) or UD (P = 0.2327). I
n hemodialysis patients without a history of transplantation, parathyr
oidectomy, or secondary amenorrhea, there was no correlation between 2
-score at any site and duration of dialysis. Thus, osteopenia in dialy
sis patients occurs in both axial and appendicular sites and sites of
compact and cancellous bone. It is more common with previous transplan
tation and secondary amenorrhea, whereas a history of parathyroidectom
y is associated with increased BMD. No relationship was found between
BMD and duration of hemodialysis, which suggests that important change
s in BMD occur during the predialysis stage of chronic renal failure.
(C) 1996 by the National Kidney Foundation, Inc.